Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Canalization and plasticity in psychopathology
Robin Carhart‐Harris, Shamil Chandaria, David Erritzøe, et al.
Neuropharmacology (2022) Vol. 226, pp. 109398-109398
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

The (In)flexible self: Psychopathology, mindfulness, and neuroscience
Fabio Giommi, Prisca R. Bauer, Aviva Berkovich‐Ohana, et al.
International Journal of Clinical and Health Psychology (2023) Vol. 23, Iss. 4, pp. 100381-100381
Open Access | Times Cited: 43
Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Psychedelic-Induced Neural Plasticity: A Comprehensive Review and a Discussion of Clinical Implications
Francesco Weiss, Anna Magnesa, Matteo Gambini, et al.
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 117-117
Open Access | Times Cited: 3
Psilocybin: From Psychiatric Pariah to Perceived Panacea
Gregory A. Fonzo, Aaron Wolfgang, Bryan Barksdale, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 54-78
Closed Access | Times Cited: 1
Psychedelic therapy in the treatment of addiction: the past, present and future
Rayyan Zafar, Maxim Siegel, Rebecca Harding, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 35
Emerging Challenges for Psychedelic Therapy
Jacob S. Aday, Robin Carhart‐Harris, Joshua D. Woolley
JAMA Psychiatry (2023) Vol. 80, Iss. 6, pp. 533-533
Closed Access | Times Cited: 32
How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change
Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 100-112
Open Access | Times Cited: 29
Psychedelics: Threshold of a Therapeutic Revolution
David J. Heal, Sharon L. Smith, Sean J. Belouin, et al.
Neuropharmacology (2023) Vol. 236, pp. 109610-109610
Open Access | Times Cited: 25
Exploring mechanisms of psychedelic action using neuroimaging
David Erritzøe, Christopher Timmermann, Kate Godfrey, et al.
Nature Mental Health (2024) Vol. 2, Iss. 2, pp. 141-153
Closed Access | Times Cited: 11
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial
David Erritzøe, Tommaso Barba, Kyle T. Greenway, et al.
EClinicalMedicine (2024), pp. 102799-102799
Open Access | Times Cited: 9
Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression
Gustavo Deco, Yonatan Sanz Perl, Samuel Johnson, et al.
Nature Mental Health (2024) Vol. 2, Iss. 9, pp. 1096-1110
Open Access | Times Cited: 8
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression
David Erritzøe, Tommaso Barba, Meg J. Spriggs, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 458-470
Open Access | Times Cited: 7
Psychedelics and the ‘inner healer’: Myth or mechanism?
Joseph Peill, M. Marguilho, David Erritzøe, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 5, pp. 417-424
Open Access | Times Cited: 7
Deep CANALs: a deep learning approach to refining the canalization theory of psychopathology
Arthur Juliani, Adam Safron, Ryota Kanai
Neuroscience of Consciousness (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 6
Navigating Groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences
Eirini K. Argyri, Jules Evans, David Luke, et al.
SSRN Electronic Journal (2024)
Closed Access | Times Cited: 6
Propofol anesthesia destabilizes neural dynamics across cortex
Adam Eisen, Leo Kozachkov, André M. Bastos, et al.
Neuron (2024) Vol. 112, Iss. 16, pp. 2799-2813.e9
Open Access | Times Cited: 6
Neural Geometrodynamics, Complexity, and Plasticity: A Psychedelics Perspective
Giulio Ruffini, Edmundo Lopez-Sola, Jakub Vohryzek, et al.
Entropy (2024) Vol. 26, Iss. 1, pp. 90-90
Open Access | Times Cited: 5
Sex differences in prenatal development of neural complexity in the human brain
Joel Frohlich, Julia Moser, Katrin Sippel, et al.
Nature Mental Health (2024) Vol. 2, Iss. 4, pp. 401-416
Open Access | Times Cited: 5
The flattening of spacetime hierarchy of the N,N-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework
Jakub Vohryzek, Joana Cabral, Christopher Timmermann, et al.
National Science Review (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 5
Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use
David S. Mathai, Daniel E. Roberts, Sandeep M. Nayak, et al.
Journal of Psychoactive Drugs (2025), pp. 1-12
Open Access
The computational unconscious: Adaptive narrative control, psychopathology, and subjective well-being
George Deane, Jonas Mago, Aikaterini Fotopoulou, et al.
(2024)
Open Access | Times Cited: 4
Predicting the outcome of psilocybin treatment for depression from baseline fMRI functional connectivity
Débora Copa, David Erritzøe, Bruna Giribaldi, et al.
Journal of Affective Disorders (2024) Vol. 353, pp. 60-69
Closed Access | Times Cited: 4
Psychedelic-assisted therapy among sexual and gender minority communities
Brady D. Hanshaw, Mark Fusunyan, Chase T. M. Anderson, et al.
Nature Mental Health (2024) Vol. 2, Iss. 6, pp. 636-644
Closed Access | Times Cited: 4
Study Protocol for ‘PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity’
Sean O’Connor, Kate Godfrey, Sara Reed, et al.
Cureus (2025)
Open Access
On the varieties of conscious experiences: Altered Beliefs Under Psychedelics (ALBUS)
Adam Safron, Arthur Juliani, Nicco Reggente, et al.
Neuroscience of Consciousness (2025) Vol. 2025, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top